Related Experiment Video

Updated: May 28, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Genistein and its synthetic analogs as anticancer agents

Qing-Shan Li1, Cui-Yun Li, Zi-Lin Li

  • 1State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, P. R.China.

Anti-Cancer Agents in Medicinal Chemistry
|November 3, 2011
PubMed

Insights

Genistein from soybeans shows anticancer effects by promoting cell death and halting cancer spread. Researchers are developing genistein analogs with enhanced cancer-fighting properties for new drug designs.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Genistein, a soy isoflavone, exhibits anticancer properties.
  • It influences cancer progression through apoptosis, cell cycle arrest, and inhibiting metastasis.

Purpose of the Study:

  • To review the anticancer effects of genistein and its derivatives.
  • To explore structure-activity relationships and mechanisms of action.
  • To guide the development of novel genistein-based anticancer drugs.

Main Methods:

  • Literature review of experimental studies on genistein and its analogs.
  • Analysis of structure-activity relationships.
  • Summary of proposed mechanisms of action.

Main Results:

  • Genistein and its synthesized analogs demonstrate significant anticancer activities.
  • Modified genistein structures can possess enhanced potency.
  • Key mechanisms include apoptosis induction and cell cycle arrest.

Conclusions:

  • Genistein and its derivatives are promising candidates for cancer therapy.
  • Understanding structure-activity relationships is crucial for drug design.
  • Further research can lead to novel, effective anticancer agents.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...